World renown George Clinical Scientific Leaders, researchers and project operations teams will be exhibiting at Booth 2626 and attending ASN Kidney Week in Washington, DC November 5 – 10, 2019.
Seven of our Scientific Leaders will be attending the ASN Kidney Week Conference:
• Vivekanand Jha
• David Wheeler
• Meg Jardine
• Martin Gallagher
• Hiddo Lambers Heerspink
• Muh Geot Wong
• Roberto Filho-Pecoits
Download this program to see a schedule of our Scientific Leaders’ presentations at ASN Kidney Week 2019.
Kidney Week provides attendees from across the globe opportunities to network, exchange knowledge and experiences within their fields, learn the latest scientific and medical advances, and listen to engaging and provocative discussions with leading experts in the field. Be sure to swing by our booth to learn more about the work we’ve done in renal clinical trials or to find out more information on our Scientific Leaders.
Get in touch today at [email protected]. Or contact us below to arrange a meeting with our scientific leaders or stop by Booth 2626 in the exhibit hall to learn more about our work in the Asia-Pacific and experience as a global CRO.
Professor Heerspink focuses on optimizing treatment strategies, finding new CKD therapeutic approaches and personalized medicine. He is Professor of Clinical Trials and Personalized Medicine and a clinical trialist at the Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen and Clinical Pharmacologist University Medical Center Groningen. His expertise includes clinical trial design and methodological aspects and statistical analyses of clinical trials.
Professor Gallagher focuses on acute kidney injury, the epidemiology of renal disease and clinical trials. He is Head of the Discipline of Medicine and Head of the South Western Sydney Clinical School at UNSW, and a practicing Clinical Academic Nephrologist at Liverpool Hospital. He was Director of the Renal and Metabolic Division at The George Institute for Global Health for 11 years and now leads the AKI program within the Division. He has worked extensively within the ANZ Society of Nephrology in renal guidelines, clinical policy and research.
Dr. Jha focuses on understanding the global societal impact of kidney diseases and development of affordable, scalable and sustainable prevention tools. He is Executive Director, The George Institute for Global Health, India; Professor and Chair of Global Kidney Health, Imperial College, London; Conjoint Professor of Medicine, University of New South Wales; Professor, Prasanna School of Public Health, Manipal Academy of Higher Education, India; and Immediate Past President (2019 – 2021) International Society of Nephrology. He has led research projects in more than 20 countries and has worked with many organizations including WHO to develop clinical practice guidelines and advocacy papers.
Dr. Wheeler’s research focuses on CKD and its complications, specifically those that increase cardiovascular disease burden and/or accelerate kidney failure progression. He heads a clinical research team at the Royal Free Hospital in London and is Professor of Kidney Medicine at University College London. He has been involved in the development of Clinical Practice Guidelines for Kidney Disease: Improving Global Outcomes (KDIGO) and was KDIGO co-chair between 2012 and 2019.
Walter E. Washington Convention Center
801 Mt Vernon Pl NW
Washington, DC
United States
Meet with George Clinical! Contact us to schedule a time now.
